Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.99 USD
5%
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Accounts Payable
|
Adaptive Biotechnologies Corp
Accounts Payable Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Accounts Payable
$12.2m
|
CAGR 3-Years
33%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Accounts Payable
$2.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Accounts Payable
$1.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Accounts Payable
$189.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Accounts Payable
$488m
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Accounts Payable
$3.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
52%
|
CAGR 10-Years
15%
|
See Also
What is Adaptive Biotechnologies Corp's Accounts Payable?
Accounts Payable
12.2m
USD
12.2m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Accounts Payable amounts to 12.2m USD.
What is Adaptive Biotechnologies Corp's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
30%
30%
Over the last year, the Accounts Payable growth was 93%. The average annual Accounts Payable growth rates for Adaptive Biotechnologies Corp have been 33% over the past three years , 30% over the past five years .
You don't have any saved screeners yet
